CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-25 | Lefenfeld Michael Director | Purchase | +2,715 | $18.44 | $50K | 25,537 |
| 2021-05-25 | RAPP MICHAEL Director | Purchase | +19,303 | $18.32 | $354K | 134,530 |
| 2021-05-25 | Sarma Purnanand D President and CEO | Purchase | +10,500 | $18.41 | $193K | 10,500 |
| 2021-05-24 | Lefenfeld Michael Director | Purchase | +600 | $17.80 | $11K | 22,822 |
| 2021-05-24 | RAPP MICHAEL Director | Purchase | +31,895 | $18.38 | $586K | 115,227 |
| 2021-05-24 | WAGENHEIM PHILIP Director | Purchase | +13,500 | $18.35 | $248K | 397,397 |
| 2021-05-24 | LAMATTINA JOHN L Director | Purchase | +338 | $18.44 | $6K | 46,726 |
| 2021-05-24 | LAMATTINA JOHN L Director | Purchase | +5,102 | $18.58 | $95K | 51,828 |
| 2021-04-19 | Roche Corleen M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-03-25 | Giesing Dennis H Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2020-11-03 | Stoneman Sandra G. Chief Legal Officer & Gen Coun | Grant or award · Employee Stock Option (Right to Buy) | +148,837 | 148,837 | ||
| 2020-11-03 | Widlitz Michael Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-11-03 | WAGENHEIM PHILIP Director | Grant or award · Stock Option (Right to Buy)(1) | +7,500 | 7,500 | ||
| 2020-11-03 | Lefenfeld Michael Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-11-03 | LAMATTINA JOHN L Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-11-03 | BARON RICHARD A Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-11-03 | RAPP MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-10-06 | Widlitz Michael Director | Conversion | +51,315 | 51,315 | ||
| 2020-10-06 | Widlitz Michael Director | Conversion · Series A Convertible Preferred Stock | −51,315 | 0 | ||
| 2020-10-06 | RAPP MICHAEL Director | Conversion | +555,554 | 555,554 |
Page 11 of 12 · 240 trades